Immunodiagnostics Market Report 2024 (Global Edition)

Global Immunodiagnostics Market Report 2024 Market Size Split by Product (Instruments, Reagents & Consumables, Software & Service), by Technology (Enzyme-linked immunosorbent assay, Chemiluminescence ...

Immunodiagnostics Market Report Description

We have various report editions of Immunodiagnostics Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Competitive Landscape of the Immunodiagnostics Market

The competitive landscape of the Immunodiagnostics market is characterized by the presence of several key players such as Abbott Laboratories, Roche Diagnostics, and Siemens Healthineers. These companies dominate through innovations in diagnostic technologies and extensive product portfolios. The market is highly competitive with frequent advancements in assays, instruments, and software solutions. Emerging players are focusing on niche technologies and specialized diagnostics to gain market share. Strategic collaborations, mergers, and acquisitions are common strategies employed to enhance market presence and expand capabilities. Additionally, regulatory compliance and technological advancements drive the competition within this rapidly evolving sector.

September of 2022: Mentalray introduced the ToRCH Panel. The company provides high-quality assays to satisfy various clinical demands with this panel. Mindray ToRCH kits can support several sample types with minimal quality control and volume, which greatly simplifies and expedites clinical detection. (Source: https://www.mindray.com/en/media-center/press/mindray-launches-high-sensitivity-and-high-specificity-torch-panel) May 2022: Thermo Fisher Scientific declared that autoimmune testing can be performed in the United States using the Phadia 2500+ line of devices. Thermo Fisher Scientific, a global leader in supporting science, provides a series of high-capacity. These user-friendly lab instruments enable dependable and unmatched high throughput for autoimmune and allergy testing. (Source: https://www.thermofisher.com/in/en/home/brands/onelambda.html?gclid=CjwKCAjw5qC2BhB8EiwAvqa41kqVLjM0iGs_NBcrkNXFy27aIwxfrk2e1BqeHSPp8yJXHQ48k34LhxoCK38QAvD_BwE&cid=0se_gaw_15012024_NW8RXG&ef_id=CjwKCAjw5qC2BhB8EiwAvqa41kqVLjM0iGs_NBcrkNXFy27aIwxfrk2e1BqeHSPp8yJXHQ48k34LhxoCK38QAvD_BwE:G:s&s_kwcid=AL!3652!3!687869616419!b!!g!!immunology%20laboratory%20tests!20947034828!166356317228&gad_source=1)

Top Companies Market Share in Immunodiagnostics Industry: (In no particular order of Rank)

• Nexus-Dx
• Omega Diagnostics Group PLC
• Quest Diagnostics Incorporated
• Avant Diagnostics
• Inc
• DiaSorin S.p.A.
• Adaptive Biotechnologies
• Abbott
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Immunodiagnostics Market

Which Region Dominates the Immunodiagnostics Market in 2024?

According to Cognitive Market Research, North America dominated the market in 2024. It accounted for around 40% of the global revenue by advanced healthcare infrastructure, high adoption of diagnostic technologies, and significant investment in research and development. The U.S. is a major contributor due to its robust healthcare system and high demand for innovative diagnostic solutions

Which Region is Expanding at the Fastest CAGR?

Asia Pacific stands out as the fastest-growing region in the Immunodiagnostics market because of its large population, expanding healthcare infrastructure, and increasing focus on disease prevention and diagnostics. The country's rapid economic growth and technological advancements contribute to its leading CAGR position in the market.

The current report Scope analyzes Immunodiagnostics Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

North America Immunodiagnostics Market

According to Cognitive Market Research, the global Immunodiagnostics market size was estimated at USD 25415.2 Million, out of which North America held the major market of more than 40% of the global revenue with a market size of USD 10166.08 million in 2024 and will grow at a compound annual growth rate (CAGR) of 3.2% from 2024 to 2031.

• According to Cognitive Market Research, the U.S. had a major share in the Immunodiagnostics market with a market size of USD 8021.04 million in 2024 and is projected to grow at a CAGR of 3.0% during the forecast period. The nation's due to advanced technology.
• The Canada Immunodiagnostics market had a market share of USD 1219.93 million in 2024 and is projected to grow at a CAGR of 4.0% during the forecast period. Canada's strict through innovation and investment.
• The Mexico Immunodiagnostics market is projected to witness growth at a CAGR of 3.7% during the forecast period, with a market size of USD 925.11 million in 2024.

Europe Immunodiagnostics Market

According to Cognitive Market Research, the global Immunodiagnostics market size was estimated at USD 25415.2 Million, out of which Europe held the market of more than 30% of the global revenue with a market size of USD 7624.56 million in 2024 and will grow at a compound annual growth rate (CAGR) of 3.5% from 2024 to 2031.

• The United Kingdom Immunodiagnostics market had a market share of USD 1280.93 million in 2024 and is projected to grow at a CAGR of 4.3% during the forecast period. In the U.K., Immunodiagnostics sales witness an upswing with advanced technology and healthcare investments.
• The France Immunodiagnostics market is projected to witness growth at a CAGR of 2.7% during the forecast period, with a market size of USD 701.46 million in 2024.
• According to Cognitive Market Research, the German Immunodiagnostics market size was valued at USD 1509.66 million in 2024 and is projected to grow at a CAGR of 3.7% during the forecast period. In Germany, Immunodiagnostics surged due to advanced technology and innovation.
• The Italy Immunodiagnostics market is projected to witness growth at a CAGR of 2.9% during the forecast period, with a market size of USD 655.71 million in 2024.
• The Russia Immunodiagnostics market is projected to witness growth at a CAGR of 2.5% during the forecast period, with a market size of USD 1181.81 million in 2024.
• The Spain Immunodiagnostics market is projected to witness growth at a CAGR of 2.6% during the forecast period with a market size of USD 625.21 million in 2024
• The Luxembourg Immunodiagnostics market is projected to witness growth at a CAGR of 3.6% during the forecast period, with a market size of USD 236.36 million in 2024.
• The Portugal Immunodiagnostics market is projected to witness growth at a CAGR of 3.3% during the forecast period, with a market size of USD 160.12 million in 2024.
• The Greece Immunodiagnostics market is projected to witness growth at a CAGR of 3.8% during the forecast period, with a market size of USD 91.49 million in 2024.
• Rest of Europe's Immunodiagnostics market is projected to witness growth at a CAGR of 2.2% during the forecast period, with a market size of USD 1181.81 million in 2024.

Asia Pacific Immunodiagnostics Market

According to Cognitive Market Research, the global Immunodiagnostics market size was estimated at USD 25415.2 Million, out of which Asia Pacific held the market of around 23% of the global revenue with a market size of USD 5845.50 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2031.

• According to Cognitive Market Research, the China Immunodiagnostics market size was valued at USD 2630.47 million in 2024 and is projected to grow at a CAGR of 6.5% during the forecast period. Immunodiagnostics surged in China due to the adoption of various technologies.
• The Japan Immunodiagnostics market is projected to witness growth at a CAGR of 5.5% during the forecast period, with a market size of USD 806.68 million in 2024.
• The India Immunodiagnostics market had a market share of USD 701.46 million in 2024 and is projected to grow at a CAGR of 8.8% during the forecast period. India is supportive of innovation, affordability, and rising demand.
• The South Korean Immunodiagnostics market is projected to witness growth at a CAGR of 6.1% during the forecast period, with a market size of USD 584.55 million in 2024.
• The Australian Immunodiagnostics market is projected to witness growth at a CAGR of 6.7% during the forecast period, with a market size of USD 303.97 million in 2024.
• The Southeast Asia Immunodiagnostics market is projected to witness growth at a CAGR of 8.0% during the forecast period, with a market size of USD 403.34 million in 2024.
• The Rest of Asia Pacific Immunodiagnostics market is projected to witness growth at a CAGR of 6.8% during the forecast period, with a market size of USD 415.03 million in 2024.

South America Immunodiagnostics Market

According to Cognitive Market Research, the global Immunodiagnostics market size was estimated at USD 25415.2 Million, out of which the Latin America market has more than 5% of the global revenue with a market size of USD 1270.76 million in 2024 and will grow at a compound annual growth (CAGR) of 4.4% from 2024 to 2031. .

• According to Cognitive Market Research, the Brazil Immunodiagnostics market size was valued at USD 543.89 million in 2024 and is projected to grow at a CAGR of 5.0% during the forecast period. Immunodiagnostics flourished in Brazil through advanced diagnostics.
• Argentina's Immunodiagnostics market had a market share of USD 213.49 million in 2024 and is projected to grow at a CAGR of 5.3% during the forecast period. Argentina's technology through advanced healthcare infrastructure.
• Colombia's Immunodiagnostics market is projected to witness growth at a CAGR of 4.2% during the forecast period, with a market size of USD 113.10 million in 2024.
• Peru Immunodiagnostics market is projected to witness growth at a CAGR of 4.6% during the forecast period, with a market size of USD 104.20 million in 2024.
• Chile's Immunodiagnostics market is projected to witness growth at a CAGR of 4.7% during the forecast period, with a market size of USD 91.49 million in 2024.
• The Rest of Latin America's Immunodiagnostics market is projected to witness growth at a CAGR of 3.5% during the forecast period, with a market size of USD 204.59 million in 2024.

Middle East and Africa Immunodiagnostics Market

According to Cognitive Market Research, the global Immunodiagnostics market size was estimated at USD 25415.2 Million, out of which the Middle East and Africa held the major market of around 2% of the global revenue with a market size of USD 508.30 million in 2024 and will grow at a compound annual growth (CAGR) of 4.7% from 2024 to 2031..

• The GCC Countries Immunodiagnostics market is projected to witness growth at a CAGR of 5.5% during the forecast period, with a market size of USD 217.55 million in 2024. Immunodiagnostics sales flourish through rising healthcare investments.
• The Egypt Immunodiagnostics market is projected to witness growth at a CAGR of 5.0% during the forecast period, with a market size of USD 53.37 million in 2024.
• The South Africa Immunodiagnostics market is projected to witness growth at a CAGR of 5.7% during the forecast period, with a market size of USD 80.31 million in 2024. Immunodiagnostics sales flourish in South Africa growth with advanced healthcare infrastructure.
• The Turkey Immunodiagnostics market is projected to witness growth at a CAGR of 4.2% during the forecast period, with a market size of USD 43.71 million in 2024.
• The Nigeria Immunodiagnostics market is projected to witness growth at a CAGR of 3.8% during the forecast period, with a market size of USD 53.37 million in 2024.
• The Rest of the MEA Immunodiagnostics market is projected to witness growth at a CAGR of 3.7% during the forecast period, with a market size of USD 59.98 million in 2024.

Immunodiagnostics Market Analysis

Immunodiagnostics Market Treatment Product Segment Analysis

According to Cognitive Market Research, instrument stands out as the dominant by providing essential tools for accurate, rapid, and automated detection of immune-related diseases. These instruments, including analyzers and automated platforms, enable high-throughput testing, which is critical for large-scale diagnostics, particularly in hospitals and laboratories. The advancement of technology in these instruments, such as enhanced sensitivity, specificity, and integration with digital systems, has improved diagnostic outcomes and efficiency. Their dominance is further driven by the increasing need for reliable diagnostic solutions in detecting infectious diseases, cancer, and autoimmune disorders, making them indispensable in the immunodiagnostic process.

Reagents & consumables emerge as the fastest-growing category in the Immunodiagnostics market due to their essential role in diagnostic testing. These materials, including antibodies, enzymes, substrates, and buffers, are crucial for the accurate detection and analysis of biomarkers in various immunodiagnostic assays. The continuous need for these consumables in routine diagnostic procedures, such as ELISA, immunoassays, and rapid tests, ensures steady demand. Additionally, advancements in reagent formulations and the growing adoption of point-of-care testing further boost their dominance. The recurring nature of consumable purchases, coupled with the expansion of immunodiagnostic applications in disease monitoring and personalized medicine, reinforces their market leadership.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Immunodiagnostics Industry. Request a Free Sample PDF!

Immunodiagnostics Market Technology Segment Analysis

According to Cognitive Market Research, the dominant category is enzyme-linked immunosorbent assay (ELISA). The ELISA segment's proven dependability and affordability have led to a rise in use. For producers concerned with guaranteeing product safety and quality control, this approach is notably prized for its capacity to identify tiny concentrations of antigens or antibodies. This is especially true for products like pool toys, which frequently come into close contact with skin and water.

The fastest-growing category in the immunodiagnostics market is chemiluminescence immunoassay (CLIA) driven by quicker processing times and improved sensitivity in comparison to ELISA. Manufacturers seeking to improve and expedite their quality assurance procedures are drawn to this technology's capacity to produce more accurate findings in shorter time frames. Technological developments that are driving down costs and increasing accessibility for CLIA are also contributing to its growth and are driving its wider use in the water and pool toy industry.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Immunodiagnostics Application Segment Analysis

Immunodiagnostics Market Application Segment Analysis

According to Cognitive Market Research, the dominant category is oncology & endocrinology, which is due to the critical role immunodiagnostic tools play in diagnosing and managing cancer and endocrine disorders. In oncology, immunodiagnostics is essential for detecting tumour markers, enabling early cancer detection, monitoring treatment response, and guiding personalized therapies. In endocrinology, they are vital for diagnosing hormonal imbalances, autoimmune conditions like diabetes, and thyroid disorders. The rising prevalence of cancer and endocrine diseases, combined with advancements in biomarker discovery and targeted therapies, drives significant demand in these areas, making them key segments in the growth and evolution of the immunodiagnostics market.

The fastest-growing category in the immunodiagnostics market is cardiac biomarkers due to their critical role in diagnosing and managing cardiovascular diseases, which are leading global health concerns. These biomarkers, such as troponin, BNP, and CK-MB, are essential for early detection, risk stratification, and monitoring of heart conditions, including myocardial infarction and heart failure. The increasing prevalence of cardiovascular diseases, coupled with the rising demand for point-of-care testing, has driven the adoption of cardiac markers. Advances in immunoassay technologies and growing awareness about cardiovascular health further boost their market share, making cardiac markers a key segment in the immunodiagnostics industry.

• Infectious diseases
• Oncology & endocrinology
• Bone & mineral diseases
• Autoimmunity disorders
• Cardiac biomarkers
• Drug monitoring
• Others

Immunodiagnostics End-User Segment Analysis

Immunodiagnostics Market End-User Segment Analysis

According to Cognitive Market Research, the dominant category is hospitals due to their extensive infrastructure and resources, enabling comprehensive testing and advanced diagnostics. They leverage high-throughput testing systems and cutting-edge technologies to provide accurate, timely results for a broad range of diseases. Hospitals benefit from economies of scale, allowing for bulk purchasing of diagnostic reagents and equipment. Their integration with specialized departments and expert personnel enhances diagnostic capabilities and patient care. Additionally, hospitals' strong relationships with diagnostic companies and research institutions facilitate access to the latest innovations, reinforcing their market leadership in immunodiagnostics.

The fastest-growing category in the Immunodiagnostics market is academic and research institutes as more and more of these organisations come to see the usefulness of these items in learning and research environments. In addition to being used recreationally, pool toys and water toys are being used by universities, schools, and research organisations to investigate hydrodynamics, buoyancy, and other aquatic phenomena. The growing body of interdisciplinary research that includes aspects of play and exploration in aquatic habitats is what is propelling the expansion of this area.

• Hospitals
• Clinical Laboratories
• Academic & research institutes
• Others

Author's Detail

Anushka Gore

Research Associate at Cognitive Market Research

LinkedIn

Profile

Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.

Author's Conclusion